This system has also been used to modify the aquaporin-1 gene in the ciliary body to reduce aqueous humor (AQH) production, thereby lowering IOP to treat ocular hypertension (OHT) and glaucoma-like optic neuropathy (GON) [2]. The gene discussed is AQP1; the disease is optic nerve disorder.